BAJAJ BROKING
The stock market is a dynamic entity with sectors that periodically come into focus. Today, we delve into the pharmaceutical sector, identifying stocks to buy. With a mix of technical analysis and fundamental insights, Bajaj Broking’s Research Desk has come up with a comprehensive overview of the top picks in the pharma sector.
The pharmaceutical sector is on an upward trajectory, driven by robust domestic demand and international acclaim for Indian pharmaceuticals. Known as the 'Pharmacy of the World,' India's pharma industry is poised for significant growth. This blog highlights key stocks in this sector that offer promising returns.
Nifty Pharma: Range Breakout
The Nifty Pharma index has recently broken out of a four-month range, indicating a resumption of its upward trend. This breakout provides a fresh entry opportunity for investors looking to capitalize on the momentum.
Bajaj Broking’s Research Desk anticipates the index to rise towards the 23,900 level, matching the price parity of the previous rally (14,544-19,397) as projected from the recent trough of 17,904.
Fundamental Outlook
India has solidified its position as a global centre for medical tourism, offering affordable treatments with cutting-edge technology, driven by numerous groundbreaking reforms and provisions. Indian medicines, known for their low cost and high quality, are favored worldwide, earning the country the title of the 'Pharmacy of the World.’ The domestic pharmaceutical industry is projected to reach US$ 57 billion by FY25, with an expected increase in operating margins of 100-150 basis points (bps).
1. Sun Pharma
Market Cap: ₹3,76,036 Cr
Sun Pharma is a leader in the domestic pharmaceutical market, driven by volume growth and new product launches. The company is expected to see significant gains due to its strategic moves and strong market presence.
Recommendation:
Technical Outlook:
Fundamental Outlook:
Taro Merger to Strengthen Balance Sheet:
Domestic Business Leadership:
2. Granules India
Market Cap: ₹12,604 Cr
Granules India is transitioning to value-added products, which is driving margins and growth. The company's focus on complex products in regulated markets is set to spur future growth.
Recommendation:
Technical Outlook:
Fundamental Outlook:
Focus on Value-Added Products:
Launch of Complex Products to Spur Growth:
The Sensex after surpassing lifetime highs earlier this week fell by 0.26% to 79,842.21 as of 12:30 PM. The Nifty 50 also saw marginal correction to 24,279.75 as of 12:30 PM on Friday, 5th July. Bank Nifty saw the biggest correction today among indices as it fell by 1% to 52,591.65, driven primarily by HDFC Bank’s 4.4% decline.
Investing in the right stocks requires careful analysis and a keen eye on market trends. Bajaj Broking’s Research Desk helps you with in-depth technical and fundamental analysis of stocks, sectors, trends, and much more. They have identified the pharma sector’s stocks to buy in their latest analysis. Stay tuned for further updates. To stay updated with the markets regularly follow Bajaj Broking’s podcast
Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.
This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For All Disclaimers Click Here: https://bit.ly/3Tcsfuc
Share this article:
Disclaimer :
The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes.
The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.
Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.
BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.
Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For more disclaimer, check here : https://www.bajajbroking.in/disclaimer
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading